As CPT1a upregulation leads to greater ROS and CD4+ T cell apoptosis, we sought to test whether blocking CPT1 affects CD4+ T cells and HCC development in the context of NAFLD. The gene discussed is CPT1A; the disease is hepatocellular carcinoma.